Current Report Filing (8-k)
January 08 2018 - 6:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
January 8, 2018
Date of Report (Date of earliest event reported)
Tocagen Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-38052
|
|
26-1243872
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
3030 Bunker Hill Street, Suite 230
San Diego, California
|
|
92109
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(858) 412-8400
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§ 240.12b2 of this chapter).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☒
Item 2.02
|
Results of Operations and Financial Condition.
|
We estimate that our cash, cash
equivalents and marketable securities were approximately $89.0 million as of December 31, 2017. This amount is preliminary and is subject to completion of financial closing procedures. As a result, this amount may differ from the amount
that will be reflected in our financial statements as of and for the year ended December 31, 2017. Based on our current plans, we estimate that the total cash used in 2018 to fund our operations, capital expenditures and debt amortization will
not exceed $50.0 million.
The information in this report is being furnished and shall not be deemed to be filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any
statements in this report regarding our business that are not historical facts may be considered forward-looking statements, including, but not limited to, statements regarding our cash burn rate. Forward-looking statements are
typically, but not always, identified by the use of words such as may, would, believe, intend, plan, anticipate, estimate, expect, and other similar
terminology. Forward-looking statements are based on current expectations of management and upon what management believes to be reasonable assumptions based on information currently available to it, and are subject to risks and
uncertainties. Such risks and uncertainties may cause actual results to differ materially from the expectations set forth in the forward-looking statements. Such risks and uncertainties include, but are not limited to, changes in plans,
expenses or uses of our capital resources and unexpected events impacting our cash burn rate, as well as other risks detailed in our recent filings on Forms
10-K
and
10-Q
with the United States Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements to reflect new information, events or circumstances, or to reflect the
occurrence of unanticipated events.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Tocagen Inc.
|
|
|
|
|
Dated: January 8, 2018
|
|
|
|
By:
|
|
/s/ Mark Foletta
|
|
|
|
|
|
|
Mark Foletta
|
|
|
|
|
|
|
Chief Financial Officer
|
Tocagen (NASDAQ:TOCA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tocagen (NASDAQ:TOCA)
Historical Stock Chart
From Apr 2023 to Apr 2024